Russian Federation: Market for Medicaments Containing Corticosteroid Hormones 2025

Market Size for Medicaments Containing Corticosteroid Hormones in the Russian Federation

The Russian medicaments containing corticosteroid hormones market skyrocketed to $X in 2021, rising by 52% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Overall, the total consumption indicated pronounced growth from 2012 to 2021: its value increased at an average annual rate of +3.7% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption decreased by -15.0% against 2019 indices. As a result, consumption attained the peak level of $X. From 2020 to 2021, the growth of the market remained at a lower figure.

Exports of Medicaments Containing Corticosteroid Hormones

Exports from the Russian Federation

After three years of growth, shipments abroad of medicaments containing corticosteroid hormones decreased by -14.1% to X tons in 2021. The total export volume increased at an average annual rate of +4.6% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The most prominent rate of growth was recorded in 2013 when exports increased by 45%. The exports peaked at X tons in 2020, and then reduced in the following year.

In value terms, medicaments containing corticosteroid hormones exports fell to $X in 2021. Overall, exports saw a pronounced descent. The most prominent rate of growth was recorded in 2020 with an increase of 25% against the previous year. Over the period under review, the exports hit record highs at $X in 2015; however, from 2016 to 2021, the exports remained at a lower figure.

Exports by Country

Uzbekistan (X tons) was the main destination for medicaments containing corticosteroid hormones exports from Russia, with a 31% share of total exports. Moreover, medicaments containing corticosteroid hormones exports to Uzbekistan exceeded the volume sent to the second major destination, Ukraine (X tons), twofold. The third position in this ranking was held by Kazakhstan (X tons), with a 12% share.

From 2012 to 2021, the average annual growth rate of volume to Uzbekistan amounted to +11.3%. Exports to the other major destinations recorded the following average annual rates of exports growth: Ukraine (+1.7% per year) and Kazakhstan (+3.6% per year).

In value terms, Uzbekistan ($X), Ukraine ($X) and Kazakhstan ($X) constituted the largest markets for medicaments containing corticosteroid hormones exported from Russia worldwide, together accounting for 59% of total exports. Belarus, Kyrgyzstan, Mongolia and Latvia lagged somewhat behind, together comprising a further 19%.

In terms of the main countries of destination, Mongolia, with a CAGR of +16.5%, recorded the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2021, the average medicaments containing corticosteroid hormones export price amounted to $X per ton, increasing by 15% against the previous year. In general, the export price, however, saw a abrupt decline. The export price peaked at $X per ton in 2012; however, from 2013 to 2021, the export prices failed to regain momentum.

Prices varied noticeably country of destination: the country with the highest price was Ukraine ($X per ton), while the average price for exports to Latvia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Mongolia (+4.7%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Corticosteroid Hormones

Imports into the Russian Federation

In 2021, medicaments containing corticosteroid hormones imports into Russia skyrocketed to X tons, rising by 39% on the previous year's figure. Over the period under review, total imports indicated buoyant growth from 2012 to 2021: its volume increased at an average annual rate of +7.2% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports decreased by -5.6% against 2019 indices. The most prominent rate of growth was recorded in 2019 when imports increased by 61% against the previous year. As a result, imports reached the peak of X tons. From 2020 to 2021, the growth of imports remained at a somewhat lower figure.

In value terms, medicaments containing corticosteroid hormones imports skyrocketed to $X in 2021. In general, total imports indicated a perceptible expansion from 2012 to 2021: its value increased at an average annual rate of +2.1% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports decreased by -18.0% against 2019 indices. The growth pace was the most rapid in 2019 when imports increased by 74%. As a result, imports attained the peak of $X. From 2020 to 2021, the growth of imports remained at a lower figure.

Imports by Country

Germany (X tons), India (X tons) and Sweden (X tons) were the main suppliers of medicaments containing corticosteroid hormones imports to Russia, with a combined 43% share of total imports. These countries were followed by Belgium, Belarus, France, Italy, Spain, the Czech Republic, the UK, Finland, Croatia and Serbia, which together accounted for a further 39%.

From 2012 to 2021, the biggest increases were recorded for Belarus (with a CAGR of +39.1%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing corticosteroid hormones suppliers to Russia were Germany ($X), Sweden ($X) and France ($X), with a combined 28% share of total imports. These countries were followed by Italy, Belgium, India, the UK, Finland, the Czech Republic, Spain, Croatia, Serbia and Belarus, which together accounted for a further 36%.

Among the main suppliers, Belarus, with a CAGR of +40.2%, recorded the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average medicaments containing corticosteroid hormones import price stood at $X per ton in 2021, growing by 6.2% against the previous year. Overall, the import price, however, recorded a pronounced contraction. The pace of growth appeared the most rapid in 2013 when the average import price increased by 12%. As a result, import price reached the peak level of $X per ton. From 2014 to 2021, the average import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Italy ($X per ton), while the price for Belarus ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Serbia (+3.2%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :